PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Fontes, A. ; Ramalho-Santos, J.* ; Zischka, H. ; Azul, A.M.*

Mushrooms on the plate: Trends towards NAFLD treatment, health improvement and sustainable diets.

Eur. J. Clin. Invest., DOI: 10.1111/eci.13667:e13667 (2021)
Postprint DOI PMC
Open Access Green
Non-alcoholic fatty liver disease (NAFLD) is a most important cause of liver disease. Similar to other non-communicable diseases (NCD), such as obesity and type II diabetes mellitus, NAFLD can strongly affected by diet. Diet-related NCD and malnutrition are rising in all regions being a major cause of the global health, economic and environmental burdens. Mushrooms, important dietary components since the hunter-gathering communities, have increasingly gained momentum in biomedical research and therapeutics due to their interplay in metabolism traits. We emphasize here the beneficial effects of mushroom-enriched diets on the homeostasis of lipid and sugar metabolism, including their modulation, but also interfering with insulin metabolism, gut microbiota, inflammation, oxidative stress and autophagy. In this review, we describe the cellular and molecular mechanisms at the gut-liver axis and the liver-white adipose tissue (WAT) axis, that plausibly cause such positive modulation, and discuss the potential of mushroom-enriched diets to prevent or ameliorate NAFLD and related NCD, also within the shift needed toward healthy sustainable diets.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
4.686
0.000
3
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Gut-liver Axis Protection ; Liver-adipose Tissue Axis ; Mushrooms ; Nafld Treatment ; Non-communicable Diseases ; Sustainable Healthy Diets; Fatty Liver-disease; Metabolic Syndrome; Ganoderma-lucidum; Oxidative Stress; Chemical-composition; Panellus-serotinus; Insulin-resistance; Grifola-frondosa; Fruiting Bodies; Gene-expression
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0014-2972
e-ISSN 1365-2362
Zeitschrift European Journal of Clinical Investigation
Quellenangaben Band: , Heft: , Seiten: , Artikelnummer: e13667 Supplement: ,
Verlag Wiley
Verlagsort Hoboken
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Toxicology and Pharmacology (TOX)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-505200-003
Förderungen mtFOIE GRAS project
FOIE GRAS project
H2020 Marie Sklodowska-Curie Actions
DOI 10.1111/eci.13667
WOS ID WOS:000696863800001
Scopus ID 85114997887
PubMed ID 34390493
Erfassungsdatum 2021-10-06
[➜Korrektur melden]